Enrolling Clinical Studies
Enrolling Clinical Trials
Monkeypox (MPx) Clinical Study
- This clinical study is for individuals 18+ years of who have tested positive for MPx.
- The purpose of this clinical study is to study the immune response in individuals who have been infected with Monkeypox.
Study Includes:
- Up to 5 blood sample collection visits. This is based on when you tested positive for Monkeypox.
- Compensation for qualified participants.
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver and is not caused by heavy alcohol use. Non-Alcoholic Steatohepatitis (NASH) is a form of NAFLD in which there is an accumulation of fat in the liver along with inflammation and damage. This can cause scarring (fibrosis) of the liver and may lead to cirrhosis in which the liver is permanently damaged. Cirrhosis of the liver may lead to liver cancer.
Symptoms include:
Most have no symptoms, but some may experience:
- Weight loss
- Fatigue
- Pain
You may qualify for this no-cost clinical trial if you:
- Are 18+ years of age
- Have been diagnosed with NASH
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
COPD is a chronic inflammatory lung disease which causes obstructed airflow from the lungs. COPD is most often caused from a smoking history and may increase your risk of heart disease and lung cancer.
Symptoms include:
- Breathing difficulty/Shortness of breath
- Coughing/Wheezing
- Chest tightness
- Sputum (mucus) production
You may qualify for this no-cost clinical trial if you:
- Are 40 - 85 years of age
- Have moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
- History of 2 moderate or 1 severe COPD exacerbations in the previous 12 months
- Use of triple (ICS/LABA/LAMA) therapy for COPD
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Gonorrhea Clinical Trial
Gonorrhea is an infection caused by a bacteria spread by sexual contact and can cause serious health problems if left untreated for too long. It is important to get tested and/or treated if you think you have gonorrhea or have a partner with gonorrhea.
Symptoms include:
- Green, yellow, or white discharge from the penis or vagina
- A burning feeling in the throat or when urinating
- Pain in the pelvis or testicles
You may qualify for this no-cost clinical trial if you:
- Are at least 12 years of age
- Have a suspected gonorrhea infection
Qualified volunteers may receive at no cost:
- Study medication for gonorrhea
- Study-related care
- Reimbursement for your travel
Idiopathic Pulmonary Fibrosis (IPF) Clinical Trial
IPF is a a chronic, progressive, irreversible, and usually lethal lung disease of unknown cause that occurs mostly in elderly adults.
Symptoms include:
- Worsening cough & shortness of breath
- Fatigue
- Unexplained weight loss
- Muscle & joint pain
You may qualify for this no-cost clinical trial if you:
- Are 40+ years of age
- Have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) within the last 3 years
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Colorectal Cancer (CRC) & Advanced Neoplasia (AN) Clinical Study
This clinical study is for individuals 45-84 years of age and are scheduled to undergo a screening colonoscopy and consider as 'average risk' for colorectal cancer.
The purpose of this clinical study is to collect blood samples to better understand the biomarkers of patients with colorectal cancer and help develop a blood-based screening test. Biomarkers are biologic features found in the blood and may be related to cancer risk.
Study Includes:
- Single visit for blood sample collection prior to your scheduled colonoscopy
- Compensation for qualified participants
Health insurance and doctor referrals are not required to participate in the clinical trials & clinical studies.
Upcoming Clinical Trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Syphilis Clinical Trial
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial